Literature DB >> 29881047

Alternative Linear Item Response Theory Observed-Score Equating Methods.

Marie Wiberg1.   

Abstract

Item response theory observed-score equating (IRTOSE) is widely used in many testing programs. The aim of this study was to empirically examine three alternative linear IRTOSE methods compared with the traditional IRTOSE method and to discuss these methods in light of previously suggested alternatives. This contribution is both conceptual, by exploring three alternative methods that fit into the current observed-score equating framework, and empirical by comparing the methods through simulations and with real data. The results show that the local linear (kernel) IRTOSE methods yield low bias and low values on loss measures. However, using only a linear IRTOSE method results in excessive bias and cannot be recommended because of the ease with which IRTOSE with full distributions can be performed. An example using real data showed considerable differences in the equated scores with the alternative methods as well as in comparison with the traditional IRTOSE method. Practical considerations are given in the concluding remarks.

Entities:  

Keywords:  IRT observed-score equating; kernel equating; linear equating; local equating; observed-score equating

Year:  2015        PMID: 29881047      PMCID: PMC5978485          DOI: 10.1177/0146621615605089

Source DB:  PubMed          Journal:  Appl Psychol Meas        ISSN: 0146-6216


  2 in total

Review 1.  Observed-score equating: an overview.

Authors:  Alina A von Davier
Journal:  Psychometrika       Date:  2013-02-05       Impact factor: 2.500

2.  Item Response Theory Observed-Score Kernel Equating.

Authors:  Björn Andersson; Marie Wiberg
Journal:  Psychometrika       Date:  2016-10-14       Impact factor: 2.500

  2 in total
  1 in total

1.  A Comparison of IRT Observed Score Kernel Equating and Several Equating Methods.

Authors:  Shaojie Wang; Minqiang Zhang; Sen You
Journal:  Front Psychol       Date:  2020-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.